Skip to content

Usher Syndrome Reference

Usher syndrome is a group of genetic conditions involving both hearing and vision. Retinitis pigmentosa causes progressive retinal degeneration, usually beginning with reduced night vision and a narrowing peripheral field. Hearing differences range from congenital profound Deafness to progressive hearing loss, depending on clinical and molecular subtype. Some forms also affect vestibular function and balance.

Usher syndrome does not produce one uniform life course. The age at which retinal changes become noticeable, the pace of visual-field narrowing, the degree of vestibular impairment, communication choices, and the practical effect of each change vary among people. RJ Whitaker and Saul Rosen share the Rosen-Whitaker family’s USH1F variant but have markedly different retinal timelines.

Classification and Genetics

The three traditional clinical types describe broad patterns rather than fixed outcomes.

  • Type I usually includes congenital severe-to-profound sensorineural hearing loss, vestibular areflexia or dysfunction, and retinitis pigmentosa beginning in childhood or adolescence.
  • Type II usually includes congenital mild-to-severe hearing loss, relatively preserved vestibular function, and later retinal onset.
  • Type III usually includes progressive hearing loss, variable vestibular involvement, and a variable retinal course.

Molecular classification identifies the gene in which the person has pathogenic variants. USH1F is caused by biallelic variants in PCDH15, which encodes protocadherin-15. The Rosen-Whitaker family’s USH1F variant is PCDH15 c.733C>T (p.Arg245Ter), historically written R245X, an Ashkenazi Jewish founder variant.

Usher syndrome is usually inherited in an autosomal recessive pattern. A person with one pathogenic variant at an Usher-associated locus is generally an unaffected carrier and has a one-in-two chance of transmitting that variant in each pregnancy. A child is affected when the child inherits pathogenic variants in both copies of the same Usher-associated gene. Carrying one variant at each of two different Usher loci does not by itself cause Usher syndrome.

When both parents carry a pathogenic variant in the same gene, each pregnancy has a one-in-four probability of an affected child, a one-in-two probability of an unaffected carrier, and a one-in-four probability of a child who inherited neither familial variant. These probabilities begin again with each pregnancy; they do not predict a family’s eventual distribution.

Symptoms and Course

Hearing and Language

Type I hearing loss is usually bilateral, congenital, and severe to profound. Newborn hearing screening can identify a need for diagnostic audiology, but the screening result itself does not establish the exact hearing level or the genetic diagnosis. Hearing aids, cochlear implants, signed languages, tactile languages, and other communication tools serve different people and goals. Early access to a complete language remains important regardless of which hearing technology a person uses.

Deaf people with Usher syndrome may identify as Deaf, DeafBlind, deafblind, blind, or through another language of their choosing. A medical diagnosis does not determine cultural identity. Saul continued to identify as Deaf and never formally adopted deafblind as an identity, while RJ used deafblind as part of his identity.

Retinitis Pigmentosa

Retinitis pigmentosa first damages retinal rod function in the typical Usher course. Night blindness and difficulty adapting between light levels often appear before the person recognizes peripheral-field loss. The field can gradually constrict into tunnel vision. Cone involvement can later reduce central acuity, color discrimination, and detailed visual access. Cataract and cystoid macular edema can add treatable causes of visual decline to the underlying retinal degeneration.

The retinal timeline varies within and across subtypes. RJ’s night blindness became apparent around seven, his peripheral field narrowed through ages eight to ten, and he was functionally deafblind by approximately twelve. Saul and Miri retained substantially more usable vision at the same ages and did not recognize their own retinal changes until adulthood. Miri noticed changes slightly earlier; Saul’s field then narrowed faster through his fifties and sixties, and Miri’s later progression brought them to comparable advanced tunnel vision in older adulthood.

Vestibular Function

Type I commonly reduces or eliminates vestibular responses. Children may sit or walk later and may use vision, touch, proprioception, and learned movement strategies to compensate. As visual access narrows, a person may need to revise balance and travel strategies because vision is less available for compensation.

The Rosen-Whitaker family has milder functional vestibular effects than the classic Type I pattern. RJ had delayed early motor milestones and lifelong balance adaptations but remained ambulatory. Saul and Miri also had mild lifelong vestibular dysfunction rather than one identical motor course.

Diagnosis and Differential Diagnosis

Evaluation can include diagnostic audiology, retinal examination, visual-field testing, electroretinography, optical coherence tomography, fundus imaging, vestibular testing, and a detailed personal and family history. Molecular testing can confirm biallelic pathogenic variants and distinguish gene-defined subtypes that may look clinically similar.

Congenital Deafness and retinitis pigmentosa may initially be treated as separate conditions, especially when the retinal findings appear years later. The differential diagnosis includes nonsyndromic genetic hearing loss, nonsyndromic retinitis pigmentosa, other syndromic forms of combined hearing and vision loss, infection, mitochondrial disease, and more than one unrelated condition in the same person.

In the Rosen family, clinicians diagnosed Saul’s and Miri’s retinitis pigmentosa without connecting it to their congenital Deafness. Their lost biological-family histories made an inherited pattern harder to reconstruct. RJ’s 2012 workup connected the sensory findings molecularly and prompted testing across the family.

Treatment, Surveillance, and Access

There is no curative treatment for Usher syndrome. Care is individualized around the person’s existing hearing, vision, balance, language, goals, and community. Investigational retinal and gene-directed therapies are specific to genes, variants, tissues, and trial criteria; research does not establish a general cure or a future treatment date.

Ophthalmologic surveillance can follow visual acuity, visual field, retinal structure and function, cataract, and macular edema. Audiologic and otologic follow-up depends on the person’s hearing and any devices used. Genetic counseling can explain inheritance, testing limits, reproductive probabilities, and implications for relatives without treating one reproductive choice as mandatory.

Communication and access may include American Sign Language, Protactile, braille, refreshable braille displays, screen readers, tactile and vibrating alerts, magnification or contrast when useful, environmental description, and accessible digital information. Protactile is a DeafBlind language and set of interactional practices organized through reciprocal touch; it is not merely visual ASL placed into another person’s hands.

Orientation-and-mobility training, a white cane, environmental mapping, tactile wayfinding, transportation planning, and skills-of-blindness training can support independent travel and daily life. Physical or vestibular therapy may help a person develop individualized balance strategies. Supports change as the person’s body, vision, environment, and priorities change.

Cochlear implantation is one possible hearing technology, not a universal requirement or uncomplicated restoration of hearing. Decisions can involve anatomy, timing, expected benefit, risk, language access, personal preference, and Deaf cultural identity. RJ’s family chose an ASL-first, nonoral language environment and did not pursue a cochlear implant.

Progressive sensory change can involve grief, stress, frustration, or isolation, but none is inevitable or the whole of deafblind life. Accessible peer community, family communication, DeafBlind-led instruction, and clinicians who can communicate directly with the person materially affect care and participation.

Historical Context

Before molecular testing, people with congenital Deafness and later retinitis pigmentosa could receive separate diagnoses for decades. Gene discovery in the late twentieth and early twenty-first centuries made it increasingly possible to connect the findings, identify molecular subtypes, test relatives, and distinguish clinically similar conditions caused by different genes.

The PCDH15 R245X founder variant was described in Ashkenazi Jewish families in 2003. The Holocaust had severed Saul’s and Miri’s biological family histories, including the ordinary intergenerational knowledge through which relatives might otherwise have recognized recurring Deafness or visual loss. Genetic testing did not restore those histories, but it gave the Rosen-Whitaker family a molecular explanation that their earlier records could not provide.

Protactile developed through DeafBlind community leadership beginning in Seattle in the late 2000s. Its emergence expanded the family’s communication possibilities when RJ’s vision narrowed and when Saul and Miri increasingly needed tactile access. Their use of Protactile was a shared language practice, not a withdrawal from family or community life.

The Rosen-Whitaker Family

RJ Whitaker

RJ was born in spring 2012. A bilateral referral on newborn hearing screening led to diagnostic audiology and an expanded genetic workup over the following weeks. Testing established profound congenital Deafness and homozygosity for the familial PCDH15 c.733C>T (p.Arg245Ter/R245X) variant, confirming USH1F in infancy.

RJ acquired ASL from infancy. His family began braille instruction around four and orientation-and-mobility training around five so that neither depended on waiting for further visual loss. Night blindness became apparent around seven, and his peripheral field narrowed through eight to ten. He began using a white cane outdoors and transitioning to Protactile at approximately ten, became fluent in Protactile by eleven, and was functionally deafblind by approximately twelve. He received ongoing ophthalmologic and genetics care through Johns Hopkins.

His family adapted the Whitaker-Rosen Family Home with tactile wayfinding, vibrating alerts, accessible controls, and furniture arrangements that supported tactile conversation. His parents, sisters, and grandparents learned Protactile with him. His grandparents’ slower but related sensory courses gave him family models for adaptation without making their bodies templates for his.

Saul Rosen and Miri Rosen

Saul and Miri were both born profoundly Deaf in occupied Warsaw in 1944, but their early access to language differed. Saul’s hearing adoptive family in New York could not provide accessible language; he acquired his first full language at the New York School for the Deaf from approximately five. Miri acquired ASL after joining the Deaf Goldfarb household in Boston at approximately two and a half and was fluent by approximately three and a half. Both had mild lifelong vestibular dysfunction and later developed retinitis pigmentosa. Miri began noticing night-vision and peripheral-field changes slightly earlier than Saul; Saul’s narrowing advanced faster through his fifties and sixties, and Miri caught up later.

Ophthalmologists diagnosed their retinal disease without connecting it to their Deafness. After RJ’s diagnosis in 2012, molecular testing confirmed Saul’s USH1F and showed that Miri’s clinically similar Type I Usher syndrome came from a different, still-unspecified Usher-related gene. The result named two conditions that had looked like one family line.

Miri learned braille in her fifties, began using a refreshable braille display for sustained reading in her seventies, used a white cane from her sixties, and began learning Protactile in 2012. Protactile became her primary face-to-face language by her late eighties. Saul adopted a white cane outdoors in his late seventies and learned Protactile in his eighties. Both retained reciprocal care, family authority, humor, and community participation as their access methods changed.

Carriers and Inheritance

Annie Whitaker inherited one USH1F R245X variant from Saul and one variant at Miri’s different Usher locus. She remained unaffected at both loci. Robbie Whitaker was an unrelated heterozygous carrier of the same USH1F founder variant. Annie and Robbie learned their carrier status after RJ’s diagnosis.

Their identical twins, Lindsay Whitaker and Leslie Whitaker, were unaffected heterozygous USH1F carriers. RJ inherited the USH1F variant from both parents and was affected. The twins can transmit their variant to a child regardless of a future partner’s genotype; a child’s risk of being affected would depend on whether the other biological parent also contributed a pathogenic PCDH15 variant.

Daily Life and Community

Usher syndrome can change how a person receives conversation, follows activity in a room, travels after dark, finds objects outside a narrowing visual field, reads, uses a screen, or recovers balance after a turn. Access depends on distance, lighting, contrast, touch, the familiarity of a route, communication partners’ skill, fatigue, and the predictability of the environment.

The same person may use visual signing at close range, Protactile, braille, a screen reader, remaining central vision, and environmental description in different combinations. A change in method does not indicate cognitive loss. Communication partners support access by identifying themselves, obtaining consent for touch, preserving reciprocal contact and feedback, describing relevant environmental changes, and making information available in the person’s chosen form.

For the Rosen-Whitaker family, access is multigenerational household practice. ASL, Protactile, spoken English, and braille coexist. Family members learn the languages and tools needed to communicate directly rather than assigning all access labor to the DeafBlind person.

Sources

Medical Conditions Genetic Conditions Sensory Disabilities DeafBlind Characters Progressive Conditions